Exchange: NASDAQ·Updated 07:30 PM EST

QTRX News

News
all
press releases
Quanterix Announces Leadership Transition Plan
Quanterix Corporation (Quanterix or the Company) (NASDAQ: QTRX), a global leader in precision biomarker science, today announced that Everett Cunningham has stepped down as President and Chief Executive Officer and as a member of the Companys Board of Directors (the Board), effective immediately...
Business Wire
Quanterix Announces Leadership Transition Plan
Quanterix Corporation (Quanterix or the Company) (NASDAQ: QTRX), a global leader in precision biomarker science, today announced that Everett Cunningham has stepped down as President and Chief Executive Officer and as a member of the Companys Board of Directors (the Board), effective immediately...
Business Wire
More News
Quanterix Corporation (NASDAQ: QTRX) today announced an exclusive distribution agreement with Sherman Abrams Laboratory, a Brooklyn-based clinical and anatomic pathology lab, to bring its LucentAD Complete blood tests to patients across New Jersey and the surrounding area. LucentAD Complete from...
Business Wire
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
(RTTNews) - Quanterix Corp (QTRX) revealed Loss for third quarter of -$21.591 million...
Nasdaq News: Markets
Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, today announced financial results for the third quarter ended September 30, 2026. We delivered higher than expected topline growth in the third quarter, with revenues up 6.3% sequentially, despite continued market...
Business Wire
Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that it will host a conference call on Monday, November 9, 2026, at 8:30 AM ET, to discuss its third quarter 2026 financial results. Quanterix will issue a press release regarding its third quarter...
Business Wire
Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, and Innovita Biological Technology Co., Ltd. (SSE: 688253.SH), a leading in vitro diagnostics company in China, today announced regulatory approvals that advance access to the Quanterix SIMOA technology and...
Business Wire
Quanterix Corporation (NASDAQ: QTRX) today reported significant progress on the Content Innovation Engine it introduced at the American Association for Cancer Research (AACR) Annual Meeting 2026, highlighting new updates at the European Society for Spatial Biology (ESSB) September 28-October 1...
Business Wire
Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that accomplished physician executive Dr. Yuri Fesko has been appointed Chief Medical Officer of the company. In this new role, he will provide medical and clinical leadership across Quanterix...
Business Wire
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets

Advertisement|Remove ads.